Amgen has created these resources as a comprehensive overview on the fundamentals of biosimilars and their impact on healthcare. Discover more on the pages linked below.
Potential Benefits & Value of Biosimilars
Promising opportunities for healthcare stakeholders
Potential Interchangeability
How a biosimilar gains a US Food and Drug Administration (FDA) interchangeability designation
Biosimilars Naming & Labeling
Policies and purpose of maintaining consistency
Biosimilars vs. Generics
Key differences in size, structure and manufacturing
